Portfolio Holdings Detail for ISIN IE00BMX0DF60
Stock Name / Fund iShares US Medical Devices UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker UMDV.AS(USD) CXE
ETF Ticker UMDV(USD) Euronext Amsterdam

Holdings detail for AORT

Stock Name	Artivion Inc
Ticker	AORT(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US2289031005
LEI	549300YTKV8DMSMG6K81

Show aggregate AORT holdings

News associated with AORT

Analysts Set Artivion, Inc. (NYSE:AORT) Target Price at $40.63: Artivion, Inc. (NYSE:AORT – Get Free Report) has earned a consensus rating of “Buy” from the seven brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. […] - 2025-09-12 02:16:54
Comparing Artivion (NYSE:AORT) and Tandem Diabetes Care (NASDAQ:TNDM): Artivion (NYSE:AORT – Get Free Report) and Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, dividends, earnings and risk. Profitability This table compares Artivion and Tandem Diabetes […] - 2025-09-11 02:46:51
Artivion (NYSE:AORT) Rating Lowered to “Hold” at Wall Street Zen: Artivion (NYSE:AORT – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Sunday. Several other analysts also recently weighed in on the company. Citizens Jmp upgraded Artivion to a “strong-buy” rating in a research report on Tuesday, May […] - 2025-08-19 02:50:52
Natixis Advisors LLC Boosts Stock Holdings in Artivion, Inc. (NYSE:AORT): Natixis Advisors LLC raised its holdings in Artivion, Inc. (NYSE:AORT – Free Report) by 16.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,615 shares of the company’s stock after purchasing an additional 1,777 shares during the period. Natixis Advisors LLC’s […] - 2025-08-13 04:30:57
Artivion (NYSE:AORT) Raised to “Buy” at Wall Street Zen: Wall Street Zen upgraded shares of Artivion (NYSE:AORT – Free Report) from a hold rating to a buy rating in a report published on Saturday. A number of other brokerages also recently commented on AORT. JMP Securities upped their price objective on shares of Artivion from $33.00 to $42.00 and gave the stock a “market […] - 2025-08-12 02:26:52
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.16 Million in Artivion, Inc. (NYSE:AORT): Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Artivion, Inc. (NYSE:AORT – Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 128,637 shares of the company’s stock, valued at approximately $3,162,000. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.30% […] - 2025-07-29 05:26:54
New York State Teachers Retirement System Reduces Position in Artivion, Inc. (NYSE:AORT): New York State Teachers Retirement System decreased its holdings in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 4.6% in the first quarter, Holdings Channel.com reports. The institutional investor owned 59,557 shares of the company’s stock after selling 2,900 shares during the quarter. New York State Teachers Retirement System’s holdings in Artivion were worth […] - 2025-07-10 04:50:54
Artivion, Inc. (NYSE:AORT) Given Average Recommendation of “Buy” by Analysts: Shares of Artivion, Inc. (NYSE:AORT – Get Free Report) have been assigned a consensus rating of “Buy” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1 […] - 2025-06-26 03:10:53
How The Parts Add Up: SPTM Targets $80: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-04 07:53:36
Artivion, Inc. (NYSE:AORT) Receives $31.40 Average PT from Analysts: Artivion, Inc. (NYSE:AORT – Get Free Report) has received an average rating of “Buy” from the six brokerages that are currently covering the firm, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among […] - 2025-06-04 02:12:54
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 24,686 Shares of Artivion, Inc. (NYSE:AORT): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its holdings in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 7.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 316,201 shares of the company’s […] - 2025-06-01 06:08:54
ProShare Advisors LLC Buys 3,683 Shares of Artivion, Inc. (NYSE:AORT): ProShare Advisors LLC grew its stake in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 44.7% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 11,924 shares of the company’s stock after acquiring an additional 3,683 shares during the period. ProShare Advisors LLC’s holdings in Artivion were worth $341,000 at the end of […] - 2025-05-29 05:04:48
Artivion, Inc. (NYSE:AORT) Shares Acquired by Deutsche Bank AG: Deutsche Bank AG increased its position in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 45.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 36,982 shares of the company’s stock after purchasing an additional 11,501 shares during the period. Deutsche Bank AG’s […] - 2025-05-26 04:34:58
BNP Paribas Financial Markets Boosts Stock Position in Artivion, Inc. (NYSE:AORT): BNP Paribas Financial Markets increased its position in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 9.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,298 shares of the company’s stock after acquiring an additional 2,724 shares during […] - 2025-05-22 04:38:48
Artivion, Inc. (NYSE:AORT) Receives $31.40 Average PT from Brokerages: Shares of Artivion, Inc. (NYSE:AORT – Get Free Report) have been given an average rating of “Buy” by the six ratings firms that are presently covering the stock, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […] - 2025-05-12 02:54:56
Artivion (NYSE:AORT) Rating Increased to Strong-Buy at Citizens Jmp: Artivion (NYSE:AORT – Get Free Report) was upgraded by equities researchers at Citizens Jmp to a “strong-buy” rating in a research report issued on Tuesday,Zacks.com reports. Several other equities analysts also recently commented on AORT. Stifel Nicolaus lowered their price objective on shares of Artivion from $33.00 to $30.00 and set a “buy” rating for […] - 2025-05-08 02:44:59
MetLife Investment Management LLC Boosts Stake in Artivion, Inc. (NYSE:AORT): MetLife Investment Management LLC boosted its stake in Artivion, Inc. (NYSE:AORT – Free Report) by 7.4% in the 4th quarter, Holdings Channel reports. The firm owned 24,103 shares of the company’s stock after purchasing an additional 1,671 shares during the period. MetLife Investment Management LLC’s holdings in Artivion were worth $689,000 at the end of […] - 2025-05-05 05:22:57
Barclays PLC Boosts Stock Holdings in Artivion, Inc. (NYSE:AORT): Barclays PLC lifted its holdings in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 1.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 71,697 shares of the company’s stock after buying an additional 820 shares during the quarter. Barclays PLC owned […] - 2025-05-02 06:02:55
Wells Fargo & Company MN Raises Stock Holdings in Artivion, Inc. (NYSE:AORT): Wells Fargo & Company MN raised its stake in Artivion, Inc. (NYSE:AORT – Free Report) by 22.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 34,823 shares of the company’s stock after purchasing an additional 6,299 shares during the period. Wells Fargo & […] - 2025-04-30 04:41:03
Invesco Ltd. Has $7.64 Million Holdings in Artivion, Inc. (NYSE:AORT): Invesco Ltd. lifted its position in Artivion, Inc. (NYSE:AORT – Free Report) by 22.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 267,067 shares of the company’s stock after purchasing an additional 49,462 shares during the quarter. Invesco Ltd.’s holdings in […] - 2025-04-25 05:08:54
Bank of Montreal Can Lowers Holdings in Artivion, Inc. (NYSE:AORT): Bank of Montreal Can lowered its position in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 29.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,135 shares of the company’s stock after selling 3,455 shares during the period. Bank of […] - 2025-04-25 05:08:49
Analysts Expect 34% Gains Ahead For IJR: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-24 08:25:25
Analyzing Artivion (NYSE:AORT) and Penumbra (NYSE:PEN): Artivion (NYSE:AORT – Get Free Report) and Penumbra (NYSE:PEN – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations. Earnings & Valuation This table compares Artivion and Penumbra”s gross […] - 2025-04-23 03:04:50
Legal & General Group Plc Trims Stake in Artivion, Inc. (NYSE:AORT): Legal & General Group Plc decreased its position in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 3.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 144,585 shares of the company’s stock after selling 5,621 shares during the quarter. Legal & General […] - 2025-04-22 05:20:50
American Century Companies Inc. Has $1.65 Million Stake in Artivion, Inc. (NYSE:AORT): American Century Companies Inc. raised its stake in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 5.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 57,771 shares of the company’s stock after purchasing an additional 2,764 shares during the quarter. American Century Companies […] - 2025-04-10 04:26:57
KLP Kapitalforvaltning AS Invests $194,000 in Artivion, Inc. (NYSE:AORT): KLP Kapitalforvaltning AS bought a new stake in Artivion, Inc. (NYSE:AORT – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 6,800 shares of the company’s stock, valued at approximately $194,000. A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AORT. Quarry LP […] - 2025-04-08 05:06:51
Artivion, Inc. (NYSE:AORT) Shares Sold by Thrivent Financial for Lutherans: Thrivent Financial for Lutherans cut its holdings in Artivion, Inc. (NYSE:AORT – Free Report) by 1.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 29,162 shares of the company’s stock after selling 446 shares during the quarter. Thrivent Financial for Lutherans’ holdings […] - 2025-04-03 04:22:46
Intech Investment Management LLC Buys 8,165 Shares of Artivion, Inc. (NYSE:AORT): Intech Investment Management LLC raised its position in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 77.5% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 18,695 shares of the company’s stock after purchasing an additional 8,165 shares during the quarter. Intech Investment Management LLC’s holdings in […] - 2025-03-25 06:29:07
Artivion, Inc. (NYSE:AORT) Position Raised by Amundi: Amundi raised its stake in Artivion, Inc. (NYSE:AORT – Free Report) by 174.8% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 18,288 shares of the company’s stock after buying an additional 11,634 shares during the quarter. Amundi’s holdings in Artivion were worth $553,000 as of its most […] - 2025-03-21 05:59:08
Illinois Municipal Retirement Fund Lowers Stock Holdings in Artivion, Inc. (NYSE:AORT): Illinois Municipal Retirement Fund lowered its stake in Artivion, Inc. (NYSE:AORT – Free Report) by 13.4% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 19,908 shares of the company’s stock after selling 3,076 shares during the period. Illinois Municipal Retirement Fund’s holdings in Artivion […] - 2025-03-05 08:46:57

iShares US Medical Devices UCITS ETF AORT holdings

Date	Number of AORT Shares Held	Base Market Value of AORT Shares	Local Market Value of AORT Shares	Change in AORT Shares Held	Change in AORT Base Value	Current Price per AORT Share Held	Previous Price per AORT Share Held
2025-11-11 (Tuesday)	5,773	USD 270,523	USD 270,523
2025-11-10 (Monday)	5,773	USD 259,670	USD 259,670	0	USD 635	USD 44.9801	USD 44.8701
2025-11-07 (Friday)	5,773	USD 259,035	USD 259,035	0	USD -15,183	USD 44.8701	USD 47.5001
2025-11-06 (Thursday)	5,773	USD 274,218	USD 274,218	-92	USD 1,437	USD 47.5001	USD 46.51
2025-11-05 (Wednesday)	5,865	USD 272,781	USD 272,781	0	USD 4,399	USD 46.51	USD 45.7599
2025-11-04 (Tuesday)	5,865	USD 268,382	USD 268,382	46	USD 2,512	USD 45.7599	USD 45.69
2025-11-03 (Monday)	5,819	USD 265,870	USD 265,870	0	USD 1,862	USD 45.69	USD 45.37
2025-10-31 (Friday)	5,819	USD 264,008	USD 264,008	0	USD -1,629	USD 45.37	USD 45.6499
2025-10-30 (Thursday)	5,819	USD 265,637	USD 265,637	-138	USD -2,368	USD 45.6499	USD 44.9899
2025-10-29 (Wednesday)	5,957	USD 268,005	USD 268,005	0	USD -1,609	USD 44.9899	USD 45.26
2025-10-28 (Tuesday)	5,957	USD 269,614	USD 269,614	0	USD 3,098	USD 45.26	USD 44.74
2025-10-27 (Monday)	5,957	USD 266,516	USD 266,516	0	USD 7,982	USD 44.74	USD 43.4

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AORT by Blackrock for IE00BMX0DF60

Show aggregate share trades of AORT

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-06 SELL -92 47.690 45.780 45.971 USD -4,229 30.44 Loss of -1,429 on sale
2025-11-04 BUY 46 46.570 45.415 45.531 USD 2,094 30.28
2025-10-30 SELL -138 46.190 44.985 45.106 USD -6,225 30.03 Loss of -2,080 on sale
2025-10-23 SELL -46 43.400 43.480 43.472 USD -2,000 29.64 Loss of -636 on sale
2025-10-22 BUY 92 43.470 43.510 43.506 USD 4,003 29.57
2025-10-20 BUY 46 42.610 42.780 42.763 USD 1,967 29.42
2025-10-16 BUY 46 41.540 42.420 42.332 USD 1,947 29.28
2025-09-25 BUY 360 40.430 40.830 40.790 USD 14,684 28.50
2025-09-24 BUY 417 40.910 41.080 41.063 USD 17,123 28.43
2025-06-27 SELL -84 31.190 31.200 31.199 USD -2,621 27.30 Loss of -327 on sale
2025-06-12 BUY 126 28.740 29.080 29.046 USD 3,660 27.14
2025-06-10 SELL -672 29.240 29.550 29.519 USD -19,837 27.11 Loss of -1,618 on sale
2025-06-09 SELL -798 29.190 29.330 29.316 USD -23,394 27.09 Loss of -1,773 on sale
2025-05-30 SELL -84 29.580 30.000 29.958 USD -2,516 27.01 Loss of -248 on sale
2025-05-19 BUY 42 29.710 29.730 29.728 USD 1,249 26.84
2025-05-09 SELL -225 28.910 29.260 29.225 USD -6,576 26.72 Loss of -563 on sale
2025-04-23 SELL -46 23.780 24.220 24.176 USD -1,112 26.96 Profit of 128 on sale
2025-04-17 SELL -45 22.930 23.280 23.245 USD -1,046 27.14 Profit of 175 on sale
2025-04-10 BUY 352 23.530 23.660 23.647 USD 8,324 27.36
2025-04-04 SELL -88 23.220 23.590 23.553 USD -2,073 27.57 Profit of 353 on sale
2025-04-02 SELL -88 25.050 25.070 25.068 USD -2,206 27.60 Profit of 223 on sale
2025-03-31 SELL -132 24.580 24.770 24.751 USD -3,267 27.67 Profit of 385 on sale
2025-03-19 SELL -42 24.370 24.640 24.613 USD -1,034 28.02 Profit of 143 on sale
2025-02-28 SELL -84 25.410 26.010 25.950 USD -2,180 28.77 Profit of 237 on sale
2025-02-05 BUY 132 31.700 32.050 32.015 USD 4,226 28.63
2025-02-04 BUY 176 30.990 30.990 30.990 USD 5,454 28.57
2025-01-29 SELL -44 31.220 31.590 31.553 USD -1,388 28.31 Loss of -143 on sale
2025-01-23 SELL -44 30.620 31.000 30.962 USD -1,362 28.03 Loss of -129 on sale
2025-01-02 SELL -84 28.080 28.630 28.575 USD -2,400 28.03 Loss of -46 on sale
2024-12-04 BUY 126 29.650 30.100 30.055 USD 3,787 27.76
2024-12-03 SELL -42 29.680 29.680 29.680 USD -1,247 27.69 Loss of -84 on sale
2024-12-02 SELL -504 29.620 29.950 29.917 USD -15,078 27.61 Loss of -1,160 on sale
2024-11-29 SELL -840 29.520 29.850 29.817 USD -25,046 27.54 Loss of -1,914 on sale
2024-11-27 SELL -126 29.050 29.210 29.194 USD -3,678 27.41 Loss of -225 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-06	SELL	-92	47.690	45.780	45.971	USD -4,229	30.44 Loss of -1,429 on sale
2025-11-04	BUY	46	46.570	45.415	45.531	USD 2,094	30.28
2025-10-30	SELL	-138	46.190	44.985	45.106	USD -6,225	30.03 Loss of -2,080 on sale
2025-10-23	SELL	-46	43.400	43.480	43.472	USD -2,000	29.64 Loss of -636 on sale
2025-10-22	BUY	92	43.470	43.510	43.506	USD 4,003	29.57
2025-10-20	BUY	46	42.610	42.780	42.763	USD 1,967	29.42
2025-10-16	BUY	46	41.540	42.420	42.332	USD 1,947	29.28
2025-09-25	BUY	360	40.430	40.830	40.790	USD 14,684	28.50
2025-09-24	BUY	417	40.910	41.080	41.063	USD 17,123	28.43
2025-06-27	SELL	-84	31.190	31.200	31.199	USD -2,621	27.30 Loss of -327 on sale
2025-06-12	BUY	126	28.740	29.080	29.046	USD 3,660	27.14
2025-06-10	SELL	-672	29.240	29.550	29.519	USD -19,837	27.11 Loss of -1,618 on sale
2025-06-09	SELL	-798	29.190	29.330	29.316	USD -23,394	27.09 Loss of -1,773 on sale
2025-05-30	SELL	-84	29.580	30.000	29.958	USD -2,516	27.01 Loss of -248 on sale
2025-05-19	BUY	42	29.710	29.730	29.728	USD 1,249	26.84
2025-05-09	SELL	-225	28.910	29.260	29.225	USD -6,576	26.72 Loss of -563 on sale
2025-04-23	SELL	-46	23.780	24.220	24.176	USD -1,112	26.96 Profit of 128 on sale
2025-04-17	SELL	-45	22.930	23.280	23.245	USD -1,046	27.14 Profit of 175 on sale
2025-04-10	BUY	352	23.530	23.660	23.647	USD 8,324	27.36
2025-04-04	SELL	-88	23.220	23.590	23.553	USD -2,073	27.57 Profit of 353 on sale
2025-04-02	SELL	-88	25.050	25.070	25.068	USD -2,206	27.60 Profit of 223 on sale
2025-03-31	SELL	-132	24.580	24.770	24.751	USD -3,267	27.67 Profit of 385 on sale
2025-03-19	SELL	-42	24.370	24.640	24.613	USD -1,034	28.02 Profit of 143 on sale
2025-02-28	SELL	-84	25.410	26.010	25.950	USD -2,180	28.77 Profit of 237 on sale
2025-02-05	BUY	132	31.700	32.050	32.015	USD 4,226	28.63
2025-02-04	BUY	176	30.990	30.990	30.990	USD 5,454	28.57
2025-01-29	SELL	-44	31.220	31.590	31.553	USD -1,388	28.31 Loss of -143 on sale
2025-01-23	SELL	-44	30.620	31.000	30.962	USD -1,362	28.03 Loss of -129 on sale
2025-01-02	SELL	-84	28.080	28.630	28.575	USD -2,400	28.03 Loss of -46 on sale
2024-12-04	BUY	126	29.650	30.100	30.055	USD 3,787	27.76
2024-12-03	SELL	-42	29.680	29.680	29.680	USD -1,247	27.69 Loss of -84 on sale
2024-12-02	SELL	-504	29.620	29.950	29.917	USD -15,078	27.61 Loss of -1,160 on sale
2024-11-29	SELL	-840	29.520	29.850	29.817	USD -25,046	27.54 Loss of -1,914 on sale
2024-11-27	SELL	-126	29.050	29.210	29.194	USD -3,678	27.41 Loss of -225 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AORT

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	80,041	47	176,798	45.3%
2025-09-18	59,596	0	161,608	36.9%
2025-09-17	78,616	0	152,137	51.7%
2025-09-16	75,727	0	121,406	62.4%
2025-09-15	51,579	0	79,408	65.0%
2025-09-12	108,096	332	154,058	70.2%
2025-09-11	66,920	0	127,073	52.7%
2025-09-10	54,477	46	119,285	45.7%
2025-09-09	71,168	0	148,994	47.8%
2025-09-08	34,390	0	107,945	31.9%
2025-09-05	37,815	0	85,481	44.2%
2025-09-04	49,027	0	117,912	41.6%
2025-09-03	45,745	0	111,180	41.1%
2025-09-02	44,646	0	120,621	37.0%
2025-08-29	40,074	0	107,852	37.2%
2025-08-28	41,758	0	166,171	25.1%
2025-08-27	71,590	11,060	181,965	39.3%
2025-08-26	53,633	0	109,717	48.9%
2025-08-25	41,748	10,102	125,508	33.3%
2025-08-22	96,458	0	278,014	34.7%
2025-08-21	48,275	0	171,466	28.2%
2025-08-20	58,438	61	158,255	36.9%
2025-08-19	62,835	11	178,563	35.2%
2025-08-18	59,035	28	152,551	38.7%
2025-08-15	56,787	0	173,968	32.6%
2025-08-14	65,657	34	240,290	27.3%
2025-08-13	77,160	33	274,283	28.1%
2025-08-12	109,949	4,900	434,604	25.3%
2025-08-11	201,428	4,429	660,130	30.5%
2025-08-08	142,292	11,350	749,390	19.0%
2025-08-07	85,116	896	210,446	40.4%
2025-08-06	118,252	1,500	214,263	55.2%
2025-08-05	28,004	39	43,656	64.1%
2025-08-04	41,014	0	61,578	66.6%
2025-08-01	60,372	0	77,216	78.2%
2025-07-31	85,870	0	147,101	58.4%
2025-07-30	77,262	11	361,133	21.4%
2025-07-29	53,902	700	94,242	57.2%
2025-07-28	29,761	0	59,954	49.6%
2025-07-25	44,214	9	67,184	65.8%
2025-07-24	55,981	0	75,665	74.0%
2025-07-23	28,822	45	50,215	57.4%
2025-07-22	40,768	4,823	64,692	63.0%
2025-07-21	37,086	0	74,472	49.8%
2025-07-18	60,571	13	87,283	69.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam